Although drugmakers took a major hit from the patent cliff, two secular trends should boost the sector in the years to come. Read More

Ignore the social and political sideshows down south; they're a distraction from the region's genuine and lasting economic progress. Read More

This ETF’s holdings have minimal exposure to potential US budget cuts. But more important, they have significant exposure to the growing demand for healthcare in the emerging markets. Read More

Investor optimism fueled by an ostensible deal over Greek debt may prove premature. Don’t get suckered into any ephemeral "relief rallies." Read More

Despite an anemic economy, retail sales have been surprisingly steady this year. But a number of factors could crimp consumer spending once the holidays are past. Read More

Demand for agricultural commodities is in a long-term uptrend, and this low-cost ETF is the best way to ensure your portfolio has exposure to it. Read More

Argentina's government has implemented questionable economic policies that render the country's once thriving markets a poor destination for investors. Read More

Last week, UBS launched an ETN that tracks a basket of mortgage REITs and employs leverage to further magnify their already eye-popping yields. Read More

Republican candidate Mitt Romney has said he won't reappoint Fed Chairman Ben Bernanke to another term. Here's what an end to monetary easing could mean for investors. Read More

President Barack Obama and his Republican challenger Mitt Romney differ sharply in their domestic policymaking, so we analyze how the election’s outcome could affect three key areas of the market. Read More